CN106215063A - A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof - Google Patents

A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof Download PDF

Info

Publication number
CN106215063A
CN106215063A CN201610774325.4A CN201610774325A CN106215063A CN 106215063 A CN106215063 A CN 106215063A CN 201610774325 A CN201610774325 A CN 201610774325A CN 106215063 A CN106215063 A CN 106215063A
Authority
CN
China
Prior art keywords
radix
parts
lung
concentrated solution
removing heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610774325.4A
Other languages
Chinese (zh)
Inventor
闫晓楠
潘勤
耿彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHONGXIN INNOVA LABORATORIES
Original Assignee
ZHONGXIN INNOVA LABORATORIES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHONGXIN INNOVA LABORATORIES filed Critical ZHONGXIN INNOVA LABORATORIES
Priority to CN201610774325.4A priority Critical patent/CN106215063A/en
Publication of CN106215063A publication Critical patent/CN106215063A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/904—Stemonaceae (Stemona family), e.g. croomia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses the Chinese medicine composition of a kind of removing heat from the lung and dissipating phlegm, belong to modern Chinese medicine field.The pharmaceutical composition of a kind of removing heat from the lung and dissipating phlegm antitussive, is made up of the crude drug of following weight: Radix Scutellariae 15 100 parts, Radix Trichosanthis 15 100 parts, Bulbus Fritillariae Thunbergii 15 50 parts, Fructus Aurantii 15 50 parts, Cortex Mori 15 50 parts, Radix Platycodonis 15 50 parts, Radix Et Rhizoma Rhei 15 50 parts, the Rhizoma Anemarrhenae 15 50 parts, Radix Ophiopogonis 15 50 parts, Exocarpium Citri Grandis 15 50 parts, Semen Armeniacae Amarum 15 50 parts, Radix Peucedani 15 50 parts, the Radix Stemonae 15 50 parts, 3 15 parts of Radix Glycyrrhizae.The invention have the advantage that the technical scheme that the present invention provides can prepare quality controllable, curative effect can be given full play to, the rational medicine of taking dose.Avoid use precursor chemicals, Simplified flowsheet, environmental protection in technique, there is significant economic and social benefit.There is significant economic and social benefit.

Description

A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
Technical field
The present invention relates to the preparation method of a kind of removing heat from the lung and dissipating phlegm antitussive medicine, belong to modern Chinese medicine field.
Background technology
Lung clearing cough suppressing phlegm transforming medicinal ball cures mainly: lung heat clearing, reduces phlegm, antitussive.The cough yellow sputum caused for lung-heat expectorant, chest and diaphragm is not smooth, Laryngalgia hoarseness, is hard and dry.
Prescription: Radix Scutellariae 96g, Radix Trichosanthis 48g, Bulbus Fritillariae Thunbergii 24g, Fructus Aurantii (removing flesh parched with bran) 24g, Radix Platycodonis 24g, Cortex Mori (honey Process) 24g, Radix Et Rhizoma Rhei 12g, Rhizoma Anemarrhenae 12g, 12g Radix Ophiopogonis, Exocarpium Citri Grandis 12g, Semen Armeniacae Amarum (peeling fry) 12g, Radix Peucedani 12g, Radix Stemonae 12g, Radix Glycyrrhizae 3g.
Preparation method: by above 14 tastes, be ground into fine powder, sieve, mixing, with water pill, it is dried, to obtain final product.
Prescription and preparation method are recorded in " Drug Standard of Ministry of Public Health of the Peoples Republic of China " Traditional Chinese medicine historical preparation the 7th, standard Numbering: WS3-B-1433-93.
This prescription with Radix Scutellariae, Radix Trichosanthis as principal agent, the clear eliminating the pathogens from the lung scorching phlegm syndrome of intestines and internal organs of the body internal organs；It is auxiliary with Radix Peucedani, Radix Platycodonis, Bulbus Fritillariae Thunbergii Control abundant expectoration due to lung-heat cough；Relievining asthma with Semen Armeniacae Amarum, Cortex Mori, stemona root cough relieving, Radix Ophiopogonis, the Rhizoma Anemarrhenae nourish lung yin, and Radix Et Rhizoma Rhei is equipped with Radix Trichosanthis Rush down large intestine internal organs heat, with Exocarpium Citri Grandis, Fructus Aurantii activating QI to eliminate phlegm, and prevent Radix Et Rhizoma Rhei, Radix Scutellariae from rushing down clearly too, for adjuvant drug；Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription. Full side ten four Chinese medicines work in coordination with onset, are exclusively used in the cough yellow sputum that treatment abundant expectoration due to lung-heat causes, and chest and diaphragm is not smooth, hoarseness of having sore throat, stool It is dried.For bronchitis, the pneumonia person that occurs above-mentioned symptom.
Owing to current this prescription of lung clearing cough suppressing phlegm transforming medicinal ball only has watered pill one dosage form, traditional handicraft is by its ten four Chinese medicine All being ground into water pill after fine powder, every dose of dose excessive (up to 6g), patient compliance is poor；In terms of quality control still Lack content measuring standard, wayward dosage form quality.This not only will directly affect the curative effect of new drug, also can affect medicine Quality monitoring.In order to solve these problems present in prior art, the present invention uses theory of Chinese medical science to analyze this prescription composition, and With reference to physicochemical property and the result of study of pharmacological action of each flavour of a drug ingredient, according to the physicochemical property of effective ingredient, and with Therapeutical effect has obtained a reasonable set, stable extraction process and the technical scheme of preparation process as foundation, research.According to this One technical scheme can prepare quality controllable, curative effect can be given full play to, the rational medicine of taking dose.Take carry more square Just, patient is prone to accept, and transports and stores and decrease expense, having significant economic and social benefit.
Chinese patent application CN200510122357.8 discloses Chinese medicine composition of a kind of removing heat from the lung and dissipating phlegm and preparation method thereof, bag Include following steps: 1. by composition of raw materials proportioning；2. Radix Scutellariae water extraction；3. Fructus Aurantii, Cortex Mori, Radix Et Rhizoma Rhei, Exocarpium Citri Rubrum, bitter Fructus Pruni Core, Radix Peucedani ethanol extraction；4. Radix Trichosanthis water extraction；5. Bulbus Fritillariae Thunbergii, Radix Platycodonis, the Radix Stemonae, the Rhizoma Anemarrhenae, Radix Ophiopogonis, Radix Glycyrrhizae water extraction； 6. extracting solution A is merged with supernatant B；7. dried object I, II, III of obtaining after said extracted are merged, i.e. obtain compositions Active component；This preparation can add relevant auxiliary materials and prepare corresponding dosage form.
In the method, Radix Scutellariae uses water to put forward the preparation method of rear acid adjustment precipitation.The method Components In Scutellaria Baicalensis cannot extract completely Entirely, extract is impure more, thus affects the therapeutic effect of medicine.The method also needs to use substantial amounts of hydrochloric acid, and hydrochloric acid is Precursor chemicals, use inconvenience, easily pollute environment.Time of repose is long, increases process time and cost, too increases The possibility polluted.The present invention is the innovation for the problems referred to above.
Summary of the invention
The technical problem to be solved in the present invention is to provide the Chinese medicine composition of a kind of removing heat from the lung and dissipating phlegm.
For achieving the above object, the present invention is by the following technical solutions:
A kind of removing heat from the lung and dissipating phlegm antitussive drug extract, is made up of the crude drug of following weight:
Radix Scutellariae 15-100 part, Radix Trichosanthis 15-100 part, Bulbus Fritillariae Thunbergii 15-50 part, Fructus Aurantii 15-50 part, Cortex Mori 15-50 part, Radix Platycodonis 15-50 part, Radix Et Rhizoma Rhei 15-50 part, Rhizoma Anemarrhenae 15-50 part, Radix Ophiopogonis 15-50 part, Exocarpium Citri Grandis 15-50 part, Semen Armeniacae Amarum 15-50 part, front 15-50 part recklessly, Radix Stemonae 15-50 part, Radix Glycyrrhizae 3-15 part；
Described removing heat from the lung and dissipating phlegm antitussive drug extract, is preferably made up of the crude drug of following weight:
Radix Scutellariae 96 parts, Radix Trichosanthis 48 parts, Bulbus Fritillariae Thunbergii 24 parts, Fructus Aurantii (removing flesh parched with bran) 24 parts, Cortex Mori (processed with honey) 24 parts, Radix Platycodonis 24 Part, Radix Et Rhizoma Rhei 12 parts, the Rhizoma Anemarrhenae 12 parts, Radix Ophiopogonis 12 parts, Exocarpium Citri Grandis 12 parts, Semen Armeniacae Amarum (peeling is fried) 12 parts, Radix Peucedani 12 parts, the Radix Stemonae 12 Part, 3 parts of Radix Glycyrrhizae.
Described removing heat from the lung and dissipating phlegm antitussive drug extract, is prepared by following methods:
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 6-12 times of water extraction 1-3 time, every time 1-3 hour, collecting volatile oil A, extracting solution concentrates, and obtains concentrated solution B；
C. remaining flavour of a drug adds 6-12 times of ethanol extraction 1-3 time, each 1-3 hour, and extracting solution concentrates, and obtains concentrated solution C；
D. concentrated solution B, C mixing, is dried, obtains dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object II is the active component of medicine of the present invention；
In above-mentioned steps
In described step b, concentrated solution proportion is X, 1.05≤X≤1.25；
In described step c, concentration of alcohol is Y1,30%≤Y1≤90%；
In described step c, concentrated solution proportion is Y, 1.05≤Y≤1.25.
Preferably
In described step b, concentrated solution proportion is X, 1.10≤X≤1.20；
In described step c, concentration of alcohol is Y1,40%≤Y1≤70%；
In described step c, concentrated solution proportion is Y, 1.10≤Y≤1.20.
A kind of removing heat from the lung and dissipating phlegm antitussive medicine, containing said medicine extract of the present invention.
Described medicine possibly together with the acceptable adjuvant of pharmaceutics, adjuvant be chosen as prior art.
Described pharmaceutical composition is peroral dosage form, selected from tablet, capsule, oral liquid, electuary, powder or pill.
A kind of preparation method of removing heat from the lung and dissipating phlegm antitussive drug extract, step is:
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 6-12 times of water extraction 1-3 time, every time 1-3 hour, collecting volatile oil A, extracting solution concentrates, and obtains concentrated solution B；
C. remaining flavour of a drug adds 6-12 times of ethanol extraction 1-3 time, each 1-3 hour, and extracting solution concentrates, and obtains concentrated solution C；
D. concentrated solution B, C mixing, is dried, obtains dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object II is the active component of medicine of the present invention；
In above-mentioned steps
In described step b, concentrated solution proportion is X, 1.05≤X≤1.25；
In described step c, concentration of alcohol is Y1,30%≤Y1≤90%；
In described step c, concentrated solution proportion is Y, 1.05≤Y≤1.25.
Preferably
In described step b, concentrated solution proportion is X, 1.10≤X≤1.20；
In described step c, concentration of alcohol is Y1,40%≤Y1≤70%；
In described step c, concentrated solution proportion is Y, 1.10≤Y≤1.20.
The invention have the advantage that the technical scheme that the present invention provides can prepare quality controllable, curative effect can be given full play to, take The rational medicine of dosage.Avoid use precursor chemicals, Simplified flowsheet, environmental protection in technique, there is significant economy And social benefit.
Describe in detail below in conjunction with specific embodiment mode, not limitation of the present invention.All open interior according to the present invention Hold this area equivalent done, belong to protection scope of the present invention.
Detailed description of the invention
Embodiment 1: prepare drug extract
One, prescription
Radix Scutellariae 960g, Radix Trichosanthis 480g, Bulbus Fritillariae Thunbergii 240g, Fructus Aurantii (removing flesh parched with bran) 240g, Radix Platycodonis 240g, Cortex Mori (processed with honey) 240g, Radix Et Rhizoma Rhei 120g, Rhizoma Anemarrhenae 120g, 120g Radix Ophiopogonis, Exocarpium Citri Grandis 120g, Semen Armeniacae Amarum (peeling is fried) 120g, Radix Peucedani 120g, the Radix Stemonae 120g, Radix Glycyrrhizae 30g
Two, preparation method
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 14 times of water extraction 6 hours, and collection is waved Hair oil A, extracting solution concentrates, obtains concentrated solution B, concentrated solution density 1.15；
C. remaining flavour of a drug adds ethanol extraction 2 times, adds 60% ethanol 6 times amount for the first time and extracts 2 hours, and second time adds 60% ethanol 4 times Amount is extracted 1.5 hours extracting solution and is merged, and concentrating under reduced pressure obtains concentrated solution C, concentrated solution density 1.15；
D. concentrated solution B, C mixing, belt drying, obtain dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object II, is the active component of medicine of the present invention；Obtain the active component 140 grams of medicine of the present invention.
Embodiment 2: prepare drug extract
One, prescription
Radix Scutellariae 960g, Radix Trichosanthis 480g, Bulbus Fritillariae Thunbergii 240g, Fructus Aurantii (removing flesh parched with bran) 240g, Radix Platycodonis 240g, Cortex Mori (processed with honey) 240g, Radix Et Rhizoma Rhei 120g, Rhizoma Anemarrhenae 120g, 120g Radix Ophiopogonis, Exocarpium Citri Grandis 120g, Semen Armeniacae Amarum (peeling is fried) 120g, Radix Peucedani 120g, the Radix Stemonae 120g, Radix Glycyrrhizae 30g
Two, preparation method
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 12 times of water extraction 8 hours, and collection is waved Hair oil A, extracting solution concentrates, obtains concentrated solution B, concentrated solution density 1.08；
C. remaining flavour of a drug adds ethanol extraction 2 times, adds 70% ethanol 8 times amount every time and extracts 1.5 hours, and extracting solution merges, and reduces pressure dense Contracting, obtains concentrated solution C, concentrated solution density 1.05；
D. concentrated solution B, C mixing, is dried, obtains dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object I, is the active component of medicine of the present invention；Obtain the active component 270 grams of medicine of the present invention.
Embodiment 3: prepare tablet
The drug extract 525g that Example 1 obtains, adds lactose 40g, microcrystalline Cellulose 40g, crospolyvinylpyrrolidone 40g, micropowder silica gel 5g, mix homogeneously, granule processed, tabletting, obtain tablet, every tablet weight 0.35g.
Embodiment 4: prepare granule
The drug extract 240g that Example 2 obtains, with mannitol 100g, xylitol 60g, lactose 30g, mix homogeneously, system Granule, obtains granule, every packed 4g.
Embodiment 5: ammonia is caused the impact of mouse cough by medicine of the present invention
One. material and method:
Medicine of the present invention: prepare by embodiment 1.
Positive control medicine: as disclosed in CN200510122357.8 prepared by method.
Lung clearing cough suppressing phlegm transforming medicinal ball: prepare according to WS3-B-1433-93 method.
Strong aqua ammonia: Dongli District, Tianjin Tai Lande chemical reagent factory
Animal: ICR mice, is provided by Beijing Vital River Experimental Animals Technology Co., Ltd., credit number: SCXK(capital) 2002-0003。
Take healthy ICR mice 84, body weight 18 ~ 22g, be randomly divided into 4 groups, i.e. model control group, medicine group of the present invention (3.6g/kg), positive control medicine group (3.6g/kg), lung clearing cough suppressing phlegm transforming medicinal ball group.Except model control group gives isopyknic pure Outside water purification, other administration groups are all by the continuous gastric infusion of above-mentioned dosage 5 days, and administration volume is 20ml/kg.Each group in last It is administered latter 1 hour, mice is placed in inverted 500ml beaker, draw after 0.3ml strong aqua ammonia injects 50mg cotton balls and put into beaker In, (typical case's cough is that mice abdominal muscle is received to observe and record the cough latent period of each group of mice and mouse cough number of times in 3 minutes Contracting, magnifies mouth, with coughing sound simultaneously), experimental data variance analysis is added up.
Two. result: be shown in Table 1.
The impact on ammonia initiation mouse cough in five days of table 1 medicine of the present invention successive administration ()
Compare * P < 0.05, * * P < 0.01 with model control group and compare # P < 0.05 with positive control medicine group
$ P < 0.05 is compared with lung clearing cough suppressing phlegm transforming medicinal ball group
Result shows: medicine group of the present invention, positive control medicine group compare with model control group, and medicine group of the present invention is with positive Property control drug group, lung clearing cough suppressing phlegm transforming medicinal ball group compare, and all have significant difference (P < 0.05, P < 0.01), point out medicine of the present invention Thing can be obviously prolonged the mouse cough incubation period of ammonia induction, reduces cough number of times.In the case of dosage is identical, and sun Property control drug group is compared, and medicine of the present invention can significantly reduce the cough number of times of ammonia inducing mouse, and and positive control drug Thing group is compared with lung clearing cough suppressing phlegm transforming medicinal group and is respectively provided with significant difference (P < 0.05), illustrates that medicine of the present invention has obvious antitussive to make With and effect be better than positive control medicine and lung clearing cough suppressing phlegm transforming medicinal ball.
Embodiment 6: the medicine of the present invention impact on mice auricle swelling
One. material and method:
Medicine of the present invention: prepare by embodiment 1.
Positive control medicine: as disclosed in CN200510122357.8 prepared by method.
Lung clearing cough suppressing phlegm transforming medicinal ball: prepare according to WS3-B-1433-93 method.
Dimethylbenzene: Dongli District, Tianjin Tai Lande chemical reagent factory
Animal: ICR mice, is provided by Beijing Vital River Experimental Animals Technology Co., Ltd., credit number: SCXK(capital) 2002-0003。
Take healthy ICR mice 84, body weight 18 ~ 22g, be randomly divided into 4 groups, i.e. model control group, medicine group of the present invention (1g/kg), positive control medicine group (1g/kg), lung clearing cough suppressing phlegm transforming medicinal ball group.Except model control group gives isopyknic pure water Outward, other administration groups are all by above-mentioned dosage gastric infusion.After being administered 30 minutes, measure every mouse right ear thickness.Measure Every mouse right ear is coated with dimethylbenzene 20 μ L and causes inflammation afterwards, after 60 minutes, again measures auris dextra thickness.After causing inflammation, auris dextra thickness just deducts Constant value is ear swelling degree.The results are shown in Table 2.
Two, result: be shown in Table 2
Table 2 medicine of the present invention xylol to mice auricle swelling impact ()
Compare * P < 0.05, * * P < 0.01 with model control group and compare #P < 0.05 with positive control medicine group
$ P < 0.05 is compared with lung clearing cough suppressing phlegm transforming medicinal ball group
Result shows: medicine group of the present invention, positive control medicine group compare with model control group, and medicine group of the present invention is with positive Property control drug group, lung clearing cough suppressing phlegm transforming medicinal ball group compare, and all have significant difference (P < 0.05, P < 0.01), point out medicine of the present invention The ear that thing can substantially suppress caused by dimethylbenzene xylene inflammation 1h to cause swells, and has the effect substantially suppressing inflammation.In the feelings that dosage is identical Under condition, comparing with positive control medicine group and lung clearing cough suppressing phlegm transforming medicinal ball group, medicine of the present invention can substantially suppress caused by dimethylbenzene xylene inflammation 1h The ear caused swells, and has the effect substantially suppressing inflammation, and equal compared with positive control medicine group and lung clearing cough suppressing phlegm transforming medicinal group There is significant difference (P < 0.05), illustrate that medicine of the present invention has significantly suppression inflammatory effect and effect to be better than positive control drug Thing and lung clearing cough suppressing phlegm transforming medicinal ball.

Claims (10)

1. a removing heat from the lung and dissipating phlegm antitussive drug extract, it is characterised in that be made up of the crude drug of following weight:
Radix Scutellariae 15-100 part, Radix Trichosanthis 15-100 part, Bulbus Fritillariae Thunbergii 15-50 part, Fructus Aurantii 15-50 part, Cortex Mori 15-50 part, Radix Platycodonis 15-50 part, Radix Et Rhizoma Rhei 15-50 part, Rhizoma Anemarrhenae 15-50 part, Radix Ophiopogonis 15-50 part, Exocarpium Citri Grandis 15-50 part, Semen Armeniacae Amarum 15-50 part, front 15-50 part recklessly, Radix Stemonae 15-50 part, Radix Glycyrrhizae 3-15 part.
A kind of removing heat from the lung and dissipating phlegm antitussive drug extract the most according to claim 1, it is characterised in that joined by following weight portion The crude drug of ratio is made:
Radix Scutellariae 96 parts, Radix Trichosanthis 48 parts, Bulbus Fritillariae Thunbergii 24 parts, Fructus Aurantii (removing flesh parched with bran) 24 parts, Cortex Mori (processed with honey) 24 parts, Radix Platycodonis 24 Part, Radix Et Rhizoma Rhei 12 parts, the Rhizoma Anemarrhenae 12 parts, Radix Ophiopogonis 12 parts, Exocarpium Citri Grandis 12 parts, Semen Armeniacae Amarum (peeling is fried) 12 parts, Radix Peucedani 12 parts, the Radix Stemonae 12 Part, 3 parts of Radix Glycyrrhizae.
A kind of removing heat from the lung and dissipating phlegm antitussive drug extract the most according to claim 1, it is characterised in that prepared by following methods Obtain:
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 6-12 times of water extraction 1-3 time, every time 1-3 hour, collecting volatile oil A, extracting solution concentrates, and obtains concentrated solution B；
C. remaining flavour of a drug adds 6-12 times of ethanol extraction 1-3 time, each 1-3 hour, and extracting solution concentrates, and obtains concentrated solution C；
D. concentrated solution B, C mixing, is dried, obtains dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object II is the active component of medicine of the present invention.
A kind of removing heat from the lung and dissipating phlegm antitussive drug extract the most according to claim 3, it is characterised in that:
In described step b, concentrated solution proportion is X, 1.05≤X≤1.25；
In described step c, concentration of alcohol is Y1,30%≤Y1≤90%；
In described step c, concentrated solution proportion is Y, 1.05≤Y≤1.25.
A kind of removing heat from the lung and dissipating phlegm antitussive drug extract the most according to claim 4, it is characterised in that:
In described step b, concentrated solution proportion is X, 1.10≤X≤1.20；
In described step c, concentration of alcohol is Y1,40%≤Y1≤70%；
In described step c, concentrated solution proportion is Y, 1.10≤Y≤1.20.
6. a removing heat from the lung and dissipating phlegm antitussive medicine, it is characterised in that: carry containing the medicine in any of the one of claim 1 to 6 Take thing.
A kind of removing heat from the lung and dissipating phlegm antitussive medicine the most according to claim 6, it is characterised in that: described medicine is possibly together with pharmaceutics Acceptable adjuvant.
8. according to a kind of removing heat from the lung and dissipating phlegm antitussive medicine described in claim 6 or 7, it is characterised in that: described pharmaceutical composition is Peroral dosage form, selected from tablet, capsule, oral liquid, electuary, powder or pill.
9. the preparation method of a kind of removing heat from the lung and dissipating phlegm antitussive drug extract described in claim 1 or 2, it is characterised in that step For:
A. each raw material is weighed by proportioning raw materials, standby；
B. Fructus Aurantii (removing flesh parched with bran), Radix Platycodonis, Exocarpium Citri Grandis, Semen Armeniacae Amarum (peeling is fried), Radix Peucedani add 6-12 times of water extraction 1-3 time, every time 1-3 hour, collecting volatile oil A, extracting solution concentrates, and obtains concentrated solution B；
C. remaining flavour of a drug adds 6-12 times of ethanol extraction 1-3 time, each 1-3 hour, and extracting solution concentrates, and obtains concentrated solution C；
D. concentrated solution B, C mixing, is dried, obtains dried object I；
E. volatile oil A uses beta-cyclodextrin inclusion compound, mixs homogeneously with dried object I, obtains dried object II；
Dried object II is the active component of medicine of the present invention.
10. the preparation method of a kind of removing heat from the lung and dissipating phlegm antitussive drug extract described in claim 1 or 2, it is characterised in that:
In described step b, concentrated solution proportion is X, 1.05≤X≤1.25, preferably 1.10≤X≤1.20；
In described step c, concentration of alcohol is Y1,30%≤Y1≤90%, preferably 40%≤Y1≤70%；
In described step c, concentrated solution proportion is Y, 1.05≤Y≤1.25, preferably 1.10≤Y≤1.20.
CN201610774325.4A 2016-08-31 2016-08-31 A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof Pending CN106215063A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610774325.4A CN106215063A (en) 2016-08-31 2016-08-31 A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610774325.4A CN106215063A (en) 2016-08-31 2016-08-31 A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106215063A true CN106215063A (en) 2016-12-14

Family

ID=58072792

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610774325.4A Pending CN106215063A (en) 2016-08-31 2016-08-31 A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106215063A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
左言富等: "《简明中成药辞典》", 31 October 2002, 上海科学技术出版社 *

Similar Documents

Publication Publication Date Title
CN102416095A (en) A Chinese medicinal composition for treating tonsillitis and pharyngitis
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN103961614B (en) Chinese medicine composition for treating respiratory disease and its production and use
CN111358906B (en) Traditional Chinese medicine composition suitable for exogenous diseases
CN106110132A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN104998162A (en) Medicine for treating cough and preparing method of medicine
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN109316551A (en) A kind of Chinese medicine composition and preparation method thereof for treating acpuei pharyngitis
CN106177689A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN101543577A (en) Traditional Chinese medicine composition for curing whelk and preparation method thereof
CN102416066A (en) A traditional Chinese medicine preparation for treating throat and oral diseases and its preparation method
CN106215063A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106237198A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106266865A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106237197A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106110131A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106177690A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106266866A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN104524187B (en) A kind of Chinese medicine preparation for the treatment of laryngopharynx swelling and pain and preparation method thereof
CN106215062A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN105381406A (en) Traditional Chinese medicine preparation for treating lung cancer and preparation method thereof
CN106266867A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN106215061A (en) A kind of compositions with removing heat from the lung and dissipating phlegm antitussive effect and preparation method thereof
CN103083524A (en) Traditional Chinese medicine granules used for treating chicken aspergillosis, and preparation method thereof
CN103432386A (en) Chinese traditional medicine preparation for treating coughs and preparation method of same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161214